Crossmark

Investigation of the in vitro antimicrobial activity of eravacycline alone and in combination with various antibiotics against MDR Acinetobacter baumanni strains

Crossref DOI link: https://doi.org/10.1186/s12866-025-03914-8

Published Online: 2025-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ataman, Merve https://orcid.org/0000-0003-1648-6896
Çelik, Berna Özbek https://orcid.org/0000-0001-8909-8398
Funding

Funding for this research was provided by:

The present work was supported by the Research Fund of Istanbul University. (TDK-2019-34283)
License Information

Text and Data Mining valid from 2025-03-26

Version of Record valid from 2025-03-26
More Information

Article History

Received: 12 November 2024

Accepted: 20 March 2025

First Online: 26 March 2025

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Istanbul University Istanbul Faculty of Medicine Clinical Research Ethics Committee Istanbul, Turkey, under the ethical code 2019/454.

: All enrolled subjects provided written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below